Radioembolization improves chance of survival for liver cancer patients, study suggests Date: August 22, 2011 Source: Wiley-Blackwell Summary: Analysis revealed survival for patients with ...

The current study evaluated the survival benefit of the liver-directed therapy, radioembolization, in 325 patients with HCC at eight European centers.

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

Most patients with advanced colorectal cancer die from hepatic metastases. Radioembolization is a technique for administering radiotherapy internally to unresectable primary or secondary hepatic ...

This article considers the case of a 58-year-old man with a history of type II diabetes, obesity and hypertension who presented with non-alcoholic steatohepatitis-related liver cirrhosis and ...

The U.K.’s National Institute for Health and Care Excellence recent recommendation that selective internal radiation therapy could be used to treat neuroendocrine tumors that have metastasized to the ...

Largest patient series to date shows that radioembolization with yttrium-90 microspheres significantly improves survival after treatment of unresectable hepatic tumors.

Transarterial yttrium-90 radioembolization (TARE) combined with second-line chemotherapy improved progression-free survival (PFS) in patients with unresectable colorectal cancer liver metastases ...

In a phase 2 study, radioembolization with yttrium-90 was safe and effective for the treatment of advanced hepatocellular carcinoma, with or without portal vein thrombosis.

The liver is the dominant site for metastatic spread of colorectal cancer. Surgical resection of isolated hepatic metastases offers the only potential cure for hepatic metastases, with 5-year survival ...

Abstract Purpose Liver metastases represent the principal cause of death in patients with advanced colorectal cancer (CRC). Injection of resin microspheres (SIR Spheres)—containing the β-emitter, ...